14-day Premium Trial Subscription Try For FreeTry Free
Soleno specializes in treating rare metabolic disorders. The company's lead therapy, DCCR, fared well as a treatment for Prader-Willi syndrome.
Soleno Therapeutics (NASDAQ: SLNO ) stock is rocketing higher on Tuesday after the biopharmaceutical company announced positive clinical trial data. The big news here is the company seeing statistical
REDWOOD CITY, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treat
Soleno Therapeutics, Inc. (SLNO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Though clinical-stage biopharmaceutical firm Soleno Therapeutics (NASDAQ: SLNO ) encountered more than its fair share of setbacks this year, it blitzed rival enterprises on Monday. Earlier this mornin
Hot penny stocks to watch with big news this week. The post Penny Stocks To Buy Now?
It is expected that innovation will continue to drive growth in the Medical-Drugs industry in 2022. KDNY, ASRT, VIRX, SLNO may prove to be good additions to one's portfolio.
Can these penny stocks make gains tomorrow? The post Good Penny Stocks to Buy Right Now?
REDWOOD CITY, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatme
REDWOOD CITY, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatm
Soleno Therapeutics Inc (NASDAQ: SLNO ) said that on January 20, 2022, the Company received official meeting minutes from the Type C meeting with the FDA''s Division of Psychiatry. The purpose of the meeting was to discuss the adequacy of the data submitted by Soleno to the FDA and possible ways to generate additional Full story available on Benzinga.com
Ambev S.A. (NYSE:ABEV) with the stream of 0.37% also noticed, India Soleno Therapeutics, Inc. (NASDAQ:SLNO) encountered a rapid change of 1.70% in the last hour of Thursdays trading session. Ambev The post Attention Seeking Stock: Ambev S.A. (NYSE:ABEV), Soleno Therapeutics, Inc. (NASDAQ:SLNO) appeared first on Stocks Equity .
Apple Inc. (NASDAQ:AAPL) with the stream of -0.65% also noticed, India Soleno Therapeutics, Inc. (NASDAQ:SLNO) encountered a rapid change of 1.56% in the last hour of Fridays trading session. Apple The post Eye-catching Shares: Apple Inc. (NASDAQ:AAPL), Soleno Therapeutics, Inc. (NASDAQ:SLNO) appeared first on Stocks Equity .
Farmmi, Inc. (NASDAQ:FAMI) with the stream of -4.71% also noticed, India Soleno Therapeutics, Inc. (NASDAQ:SLNO) encountered a rapid change of -4.68% in the last hour of Tuesdays trading session. Farmmi, The post Analysts Recommendation in Spotlight: Farmmi, Inc. (NASDAQ:FAMI), Soleno Therapeutics, Inc. (NASDAQ:SLNO) appeared first on Stocks Equity .
Soleno Therapeutics (NASDAQ:SLNO) was downgraded by Zacks Investment Research from a buy rating to a hold rating in a report released on Friday, Zacks.com reports. According to Zacks, Soleno Therapeutics Inc. is a healthcare company. It develops and commercializes diagnostics, devices and therapeutics addressing unmet medical needs. The Company offers products consists of CoSense end-tidal [] The post Soleno Therapeutics (NASDAQ:SLNO) Lowered to Hold at Zacks Investment Research appeared first on ETF Daily News .
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE